Renasant Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Renasant Bank's PFE Position: Q1 2026 in Review
Renasant Bank sold out of Pfizer (PFE) in Q1 2026, closing a stake of 15,215 shares — an estimated $379K sold.
Renasant Bank first reported a position in PFE in Q4 2020 and held it in 14 quarters. The position peaked at $1.17M in Q3 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Renasant Bank reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Renasant Bank sold 15,215 Pfizer shares in Q1 2026, an estimated $379K.
- Renasant Bank first reported a position in Pfizer in Q4 2020 and held it in 14 quarters.
- Renasant Bank's Pfizer position peaked at $1.17M in Q3 2025.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Renasant Bank's 13F filing for Q1 2026, filed 29 Apr 2026.